Drawing for NOVABIOSIS

USPTO serial 87712107

NOVABIOSIS

Reviewed by CopyMark Law Group

Reg. 5513360Status 701Registered
Filing date
Status date
Registration date
Jul 10, 2018
Examiner
BELENKER, ESTHER
Law office
Historical data usage

What this means

Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with NOVABIOSIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Victoria Friedman

Victoria Friedman Dennemeyer & Associates, LLC230 W. Monroe St.Suite 2100Chicago, OH 60606

Goods and services

ClassDescriptionStatusFirst use
035Procurement services, namely, receiving and placing organs, human cells and living tissues with research facilities; commercial intermediation services to place organs, human cells and living tissues to researchersACTIVE—
042Scientific and technological services, namely, research and design in the field of biotechnology; pharmaceutical research services; pharmaceutical products development; medical laboratory services; consulting services in the fields of biotechnology, pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; providing organs, human cells and living tissues to researchers for scientific research in the pharmaceutical and biotechnology fields; scientific project management services in the field of biotechnology research, pharmaceutical research and development; laboratory testing in the field of biotechnology research; organ and tissue bank services for scientific research purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 7, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Mar 7, 20258.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Mar 7, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 10, 2024ES8RTEAS SECTION 8 RECEIVED—
Jul 10, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 10, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 10, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 24, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 24, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 4, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 21, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 19, 2018DOCKASSIGNED TO EXAMINER—
Feb 21, 2018AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Feb 15, 2018ALIEASSIGNED TO LIE—
Feb 9, 2018PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Dec 18, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 11, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance